United States Patent (19) 11 Patent Number: 6,005,000 Hopper Et Al

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent (19) 11 Patent Number: 6,005,000 Hopper Et Al US006005000A United States Patent (19) 11 Patent Number: 6,005,000 Hopper et al. (45) Date of Patent: Dec. 21, 1999 54) 5,5-DISUBSTITUTED-3, 4-DIHYDROXY-2(5H)- King and Burns, 1975, the Second conference on Vitamin C, FURANONES AND METHODS OF USE the New York Acadeny of Science, New York. THEREFOR Lafont et al., 1995, J. Clin Invest 95:1018–25. Mansuy et al., 1996, Biochem Biophys Res Comm 75 Inventors: Allen T. Hopper, Somerset, N.J.; John 135:1015-21. A. Ziemniak, Gwynedd Valley; Robert Mantri and Witiak, 1994, Curr Med Chem 1:328-55. E. Johnson, Collegeville, both of Pa. Marshall et al., 1986, J Org Chem 51:858–63. Maxwell, 1995, Drugs 49:345–61. 73 Assignee: Oxis International, Inc., Portland, Millar et al., 1996, J Org Chem 51:4726–8. Oreg. Nicolaou and Webber, 1984, J. Chem Soc, Chem Commun 350-1. 21 Appl. No.: 08/915,099 Nihiro et al., 1992, J Med Chem 35:1618–23. Nunes et al., 1995, Thromb Vasc Biol 15:156-65. 22 Filed: Aug. 20, 1997 Ochiai et al., 1991.J Am Chem Soc 113:1319–23. Related U.S. Application Data O'Sullivan et al., 1992, Biochem Biophys Res Comm 60 Provisional application No. 60/024,440, Aug. 22, 1996, and 187:1123-7. provisional application No. 60/024,586, Aug. 26, 1996. Rabinovici et al., 1993, J Appl Physiol 74:1791–802. Remacle et al., 1995, Mutat Res 316:103–22. 51) Int. Cl. ....................... C07D 307/62; A61K 31/375 Saeva et al., 1991, J Am Chem Soc 113:5333–7. 52 U.S. Cl. ............................................. 514/473; 549/315 Schank, 1972, Synthesis 176–90. 58 Field of Search .............................. 549/315; 514/473 Schreck et al., 1992, Free Rad Res Comms 17:221–37. Shimuzu et al., 1984, Pro Natl Acad Sci USA 81:689–93. 56) References Cited Silverman, 1992, The Organic Chemistry of Drug Design and Drug Action, Academic Press, San Diego, CA, 19-20. U.S. PATENT DOCUMENTS Steinberg, 1995, Lancet 346:36–8. 5,071,872 12/1991. Witiak et al. ........................... 514/465 Stork and Rychnovsky, 1987, JAm Chem Soc 109:1564–5. 5,095,126 3/1992 Witiak et al. ... 549/315 Sun, 1990, Free Rad Biol & Med 8:583–99. 5,185.366 2/1993 Witiak et al. ... ... 514/456 Triozzi et al., 1993, Int J Immunopharmac 15:47-54. 5,288,751 2/1994 Brooks et al. ... ... 514/438 Wang et al., 1996, Pharm Exp Therap 277:714–20. 5,298,526 3/1994 Witiak et al. ... ... 514/473 Wimalasena et al., 1994, Biochem Biophys Res Comm 5,399,721 3/1995 Hopper et al. ... ... 549/315 200:113-9. 5,504,107 4/1996 Mantri et al. ........................... 549/315 5,504,108 4/1996 Witiak et al. ........................... 514/473 Witiak et al., 1982, J Med Chem 25:90–3. 5,534,540 7/1996 Ulrich et al. ............................ 514/473 Witiak et al., 1986, J Med Chem 29:2170–4. Witiak et al., 1987, J Org Chem 52:2324-7. FOREIGN PATENT DOCUMENTS Witiak et al., 1987, Actual Chim Therap 15:41–62. 4–29985 1/1992 Japan. Witiak et al., 1988, J Med Chem 31:1437–45. WO95/32194 11/1995 WIPO. Witiak et al., 1992, in Trends in Medicinal chemistry '90, Proceeding of the XIth Internatinal Symposiumon Medici OTHER PUBLICATIONS nal Chemistry, Jerusalem, Israel, Sep. 2-7, Sarel et al eds. Alami et al., 1993, Tetrahedron Lett 34:6403–6. Blackwell Scientific Publicstions, Oxford, London:243-56. Berson and Greenbaum, 1958, JAm Chem Soc 80:653-6. Bisby et al., 1995, Free Rad Biol Med 20:411–20. Primary Examiner Bernard Dentz Boopathy and Baiasubramanian, 1968, Biochem J Attorney, Agent, or Firm-Klauber & Jackson 239:371-7. 57 ABSTRACT Brown, 1975, Organic Syntheses via Boranes, John Wiley and Sons, New York, 100, 178. The present invention relates to synthetic methods for the Buckle and Fenwick, 1989, J Chem Soc Perken Trans production of both optically active and racemic 5,5- 1477-82. disubstituted-3,4-dihydroxy-2(5H)-furanones; 5-(4-aryl)-3- Buffinton and Doe, 1995, Free Rad Biol Med 19:911-8. butynyl)-3,4-dihydroxy-2(5H)-furanones; 5-(2-arylthio) Bundy et al., 1995, J Med Chem 38:4161-3. ethyl-3,4-dihydroxy-2(5H)-furanones; and 5-(2-aryloxy) Coyle et al., 1993, Science 262:689–95. ethyl-3,4-dihydroxy-2(5H)-furanones. This invention DeJarlais et al., 1980, Synth Commun 10:653–60. further relates to the use of the above mentioned compounds Egan and Gale, 1985, J Biol Chem 260;11554–9. as anti-inflammatory agents through their action as mixed Evans et al., 1987, Biochem Pharm 36:2035-7. inhibitors of lipid peroxidation, 5-lipoxygenase, Frimer et al., 1995, J Org Chem 60:4510–20. cyclooxygenase-1 and cyclooxygenase-2. The invention fur Grisar et al., 1995, J Med Chem 38:453–8. ther relates to the use of Such compounds in the treatment of Gross et al., 1994, Hepato-Gastroenterol 41:320-7. chronic inflammatory disorderS Such as asthma, rheumatoid Halliwell, 1987, FASEB J 1:358-64. arthritis, inflammatory bowel disease, atherosclerosis, acute Halliwell, 1991, Drugs 42:569–605. respiratory distress Syndrome, and central nervous System Hopper et al. (1995) J. Org. Chem. 60:3334-41. disorderS Such as Alzheimer's and Parkinson's disease Hvoslef and Pedersen, 1979, Acta Chemica Scand B wherein reactive oxygen species and inflammatory media 33:503-11. tors are contributing deleterious factors. Kato et al., 1988, J Med Chem 31:793–8. Kerwin, 1995, J Med Chem 38:4343-62. 15 Claims, No Drawings 6,005,000 1 2 5,5-DISUBSTITUTED-3, 4-DIHYDROXY-2(5H)- Thus, there exists a need for new therapeutic agents which FURANONES AND METHODS OF USE exhibit activity as antioxidants and arachidonic acid metabo THEREFOR lism inhibitors. It is to this aim that the present invention is directed. This application claims priority from Provisional appli cations Ser. Nos. 60/024,440 filed on Aug. 22, 1996, and SUMMARY OF THE INVENTION 60/024,586 filed Aug. 26, 1996. FIELD OF THE INVENTION The present invention relates to 5-substituted and 5.5- The present invention relates generally to 5-Substituted disubstituted-3,4-dihydroxy-2(5H)-furanones of the general and 5,5-disubstituted-3,4-dihydroxy-2(5H)-furanones, 1O formula I methods of preparation therefor, and methods for their use. BACKGROUND OF THE INVENTION (I) The aci-reductone 4-(4-chlorophenyl)-2-hydroxytetronic R O acid compound (CHTA) possesses antilipidemic and anti 15 aggregatory properties which differ from those of the clas Sical phenoxyactetic acids as has been disclosed in Witiak et Aryl-(L) (CH2) 2 OH al., J. Med. Chem., 1988, 31:1434-1445 and Kamanna et al., Lipids, 1989, 24:25-32. Although unsubstituted-, 2-alkyl OH and 2-acyltetronic acids are frequently found in nature, the 2-hydroxy Substituted tetronic acid redox System is found wherein R is hydrogen, phenyl or lower alkyl, L is a linker only in Vitamin C and its closely related relatives moiety Selected from the group consisting of oxygen, Sulfur, (isoascorbic acid, erythroascorbic acid) and derivatives, and nitrogen, acetylene, a cis or trans carbon-carbon double the macrollide antibiotic, chlorothricin. bond, an ester, carbonate, urea, amide and carbamate; m is The antiaggregatory activities of 2-hydroxytetronic acid 25 aci-reductone compound (CHTA) are of interest since blood 0 or 1; n is 0 to 4; Aryl is a substituted or unsubstituted aryl platelets are involved in the genesis of atherosclerosis. group; with the proviso that when R is hydrogen, then either 2-Hydroxytetronic acid aci-reductones inhibit collagen m or n is not Zero, and the pharmaceutically acceptable Salts induced human platelet aggregation and Secretion of 'CI thereof. Serotonin in a concentration-dependent manner at equivalent In various preferred embodiments of the present doses, as reported in Witiak et al., J. Med. Chem., 1982, invention, these compounds are represented by four struc 25:90-93. The CHTA compound inhibits platelet function tural Subclasses of compounds. Thus, in one preferred by a similar mechanism, involving arachidonic acid release. embodiment, the compounds are 5,5-disubstituted-3,4- Redox analogues, Such as 2-hydroxytetronic acid, function dihydroxy-2(5H)-furanones of the structural formula Ia as antioxidants in membranes or interfere with free radical 35 processes involved in the biosynthetic elaboration of cyclic (Ia) prostaglandin endoperoxides (PGG and PGH), and, Subsequently, thromboxane A from arachidonic acid. The development of dual antioxidant-arachidonic acid (AA) metabolism inhibitors may provide added benefits 40 OH over existing drugs for the treatment of diseases associated with oxidative StreSS and inflammation. Numerous condi OH tions including asthma, rheumatoid arthritis, irritable bowel disease (IBD), adult respiratory distress syndrome (ARDS), atherosclerosis, ischemia/reperfusion injury, restenosis, neu 45 wherein R and Aryl are as hereinbefore defined. Most rodegenerative disorders and initiation and promotion of preferably, in the compounds of formula (Ia), R is a methyl, carcinogenesis correlate with abnormally high levels of 1-propyl or 2-methylpropyl group; and Aryl is a phenyl, or reactive oxygen species (ROS). Antioxidant-based therapies Substituted phenyl, such as 1,1'-biphenyl, 4-chlorophenyl or including both natural antioxidants (e.g., vitamin E, Vitamin 2-methylpropylphenyl group. C and SOD), and Synthetic antioxidants (e.g., 4-aryl-2- 50 In a Second preferred embodiment, the compounds are hydroxytetronic acids', 2-O-alkyl ascorbic acids, probucol 5-(aryl alkynyl)-3,4-dihydroxy-2(5H)-furanones of the and tirilazad meSylate) have been, or are currently being, structural formula Ib investigated for the treatment of a number of these condi tions.
Recommended publications
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Chlorinated and Polycyclic Aromatic Hydrocarbons in Riverine and Estuarine Sediments from Pearl River Delta, China
    Environmental Pollution 117 (2002) 457–474 www.elsevier.com/locate/envpol Chlorinated and polycyclic aromatic hydrocarbons in riverine and estuarine sediments from Pearl River Delta, China Bi-Xian Maia,*, Jia-Mo Fua, Guo-Ying Shenga, Yue-Hui Kanga, Zheng Lina, Gan Zhanga, Yu-Shuan Mina, Eddy Y. Zengb aState Key Lab Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, PO Box 1130, Guangzhou, Guangdong 510640, People’s Republic of China bSouthern California Coastal Water Research Project, 7171 Fenwick Lane, Westminster, CA 92683, USA Received 5 January 2001; accepted 3 July 2001 ‘‘Capsule’’: Sediments of the Zhujiang River and Macao Harbor have the potential to be detrimental to biological systems. Abstract Spatial distribution of chlorinated hydrocarbons [chlorinated pesticides (CPs) and polychlorinated biphenyls (PCBs)] and poly- cyclic aromatic hydrocarbons (PAHs) was measured in riverine and estuarine sediment samples from Pearl River Delta, China, collected in 1997. Concentrations of CPs of the riverine sediment samples range from 12 to 158 ng/g, dry weight, while those of PCBs range from 11 to 486 ng/g. The CPs concentrations of the estuarine sediment samples are in the range 6–1658 ng/g, while concentrations of PCBs are in the range 10–339 ng/g. Total PAH concentration ranges from 1168 to 21,329 ng/g in the riverine sediment samples, whereas the PAH concentration ranges from 323 to 14,812ng/g in the sediment samples of the Estuary. Sediment samples of the Zhujiang River and Macao harbor around the Estuary show the highest concentrations of CPs, PCBs, and PAHs. Possible factors affecting the distribution patterns are also discussed based on the usage history of the chemicals, hydrologic con- dition, and land erosion due to urbanization processes.
    [Show full text]
  • Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium Fortunei
    International Journal of Molecular Sciences Article Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium fortunei Chun-Hao Chang 1, Semon Wu 2, Kai-Cheng Hsu 3,4, Wei-Jan Huang 5,6 and Jih-Jung Chen 7,8,9,* 1 Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; [email protected] 2 Department of Life Science, Chinese Culture University, Taipei 110, Taiwan; [email protected] 3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; [email protected] 4 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan 5 Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; [email protected] 6 Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan 7 Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 8 Faculty of Pharmacy, National Yang-Ming University, Taipei 112, Taiwan 9 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2826-7195; Fax: +886-2-2823-2940 Abstract: Five new compounds, eupatodibenzofuran A (1), eupatodibenzofuran B (2), 6-acetyl-8- methoxy-2,2-dimethylchroman-4-one (3), eupatofortunone (4), and eupatodithiecine (5), have been isolated from the aerial part of Eupatorium fortunei, together with 11 known compounds (6-16).
    [Show full text]
  • Kinetic Study of Decomposition of Azo Dyes and Phenol in Advanced Oxidation Processes: Reaction Mechanisms, Pathways and Intermediates
    Copyright Warning & Restrictions The copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyrighted material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction. One of these specified conditions is that the photocopy or reproduction is not to be “used for any purpose other than private study, scholarship, or research.” If a, user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of “fair use” that user may be liable for copyright infringement, This institution reserves the right to refuse to accept a copying order if, in its judgment, fulfillment of the order would involve violation of copyright law. Please Note: The author retains the copyright while the New Jersey Institute of Technology reserves the right to distribute this thesis or dissertation Printing note: If you do not wish to print this page, then select “Pages from: first page # to: last page #” on the print dialog screen The Van Houten library has removed some of the personal information and all signatures from the approval page and biographical sketches of theses and dissertations in order to protect the identity of NJIT graduates and faculty. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted.
    [Show full text]
  • Guidance on Information Requirements and Chemical Safety Assessment Chapter R.6: Qsars and Grouping of Chemicals
    Guidance on information requirements and chemical safety assessment Chapter R.6: QSARs and grouping of chemicals May 2008 Guidance for the implementation of REACH LEGAL NOTICE This document contains guidance on REACH explaining the REACH obligations and how to fulfil them. However, users are reminded that the text of the REACH regulation is the only authentic legal reference and that the information in this document does not constitute legal advice. The European Chemicals Agency does not accept any liability with regard to the contents of this document. © European Chemicals Agency, 2008 Reproduction is authorised provided the source is acknowledged. 2 CHAPTER R.6 – QSARS AND GROUPING OF CHEMICALS PREFACE This document describes the information requirements under REACH with regard to substance properties, exposure, use and risk management measures, and the chemical safety assessment. It is part of a series of guidance documents that are aimed to help all stakeholders with their preparation for fulfilling their obligations under the REACH regulation. These documents cover detailed guidance for a range of essential REACH processes as well as for some specific scientific and/or technical methods that industry or authorities need to make use of under REACH. The guidance documents were drafted and discussed within the REACH Implementation Projects (RIPs) led by the European Commission services, involving stakeholders from Member States, industry and non-governmental organisations. These guidance documents can be obtained via the website of
    [Show full text]
  • Dibenzothiophene (DBT), and Carbazole (CA) from Benzofuran (BF), Benzothiophene (BT), and Indole (IN) with Cyclopentadienyl Radical
    International Journal of Molecular Sciences Article The Gas-Phase Formation Mechanism of Dibenzofuran (DBF), Dibenzothiophene (DBT), and Carbazole (CA) from Benzofuran (BF), Benzothiophene (BT), and Indole (IN) with Cyclopentadienyl Radical 1, 1, 1,2 1 1,2, 3 Xuan Li y, Yixiang Gao y, Chenpeng Zuo , Siyuan Zheng , Fei Xu *, Yanhui Sun and Qingzhu Zhang 1 1 Environment Research Institute, Shandong University, Qingdao 266237, China; [email protected] (X.L.); [email protected] (Y.G.); [email protected] (C.Z.); [email protected] (S.Z.); [email protected] (Q.Z.) 2 Shenzhen Research Institute, Shandong University, Shenzhen 518057, China 3 College of Environment and Safety Engineering, Qingdao University of Science & Technology, Qingdao 266042, China; [email protected] * Correspondence: [email protected]; Tel.: +86-532-58631992 These authors contributed equally to this article. y Received: 11 August 2019; Accepted: 28 October 2019; Published: 31 October 2019 Abstract: Benzofuran (BF), benzothiophene (BT), indole (IN), dibenzofuran (DBF), dibenzothiophene (DBT), and carbazole (CA) are typical heterocyclic aromatic compounds (NSO-HETs), which can coexist with polycyclic aromatic hydrocarbons (PAHs) in combustion and pyrolysis conditions. In this work, quantum chemical calculations were carried out to investigate the formation of DBF, DBT, and CA from the reactions of BF, BT, and IN with a cyclopentadienyl radical (CPDyl) by using the hybrid density functional theory (DFT) at the MPWB1K/6-311+G(3df,2p)//MPWB1K/6-31+G(d,p) level. The rate constants of crucial elementary steps were deduced over 600 1200 K, using canonical − variational transition state theory with a small-curvature tunneling contribution (CVT/SCT).
    [Show full text]
  • Questions for the Record Public Meeting on the Petition Regarding Additive Organohalogen Flame Retardants U.S
    Questions for the Record Public Meeting on the Petition Regarding Additive Organohalogen Flame Retardants U.S. Consumer Product Safety Commission Bethesda, MD Part 3 of 4: This file contains the questions and responses for presenters 25 through 27. Panel Presenter Affiliation Notes Panel 1 1 Linda Birnbaum, Ph.D. NIEHS/National Toxicology Program Panel 2 2 William Wallace Consumers Union 3 Eve Gartner Earthjustice Northeast Office 4 Simona Balan, Ph.D. Green Science Policy Institute Joint response 5 Arlene Blum, Ph.D. 6 Miriam Diamond, Ph.D. University of Toronto Panel 3 7 Jennifer Lowery, MD, FAAP American Academy of Pediatrics 8 Patrick Morrison International Association of Fire Fighters 9 Luis Torres League of United Latin American Citizens 10 Maureen Swanson, MPA Learning Disabilities Association of America 11 Daniel Penchina The Raben Group/Breast Cancer Fund American Chemistry Council/North American Panel 4 12 Robert Simon Flame Retardant Alliance 13 Michael Walls American Chemistry Council No response 14 Matthew S. Blais, Ph.D. Southwest Research Institute 15 Thomas Osimitz, Ph.D. Science Strategies Information Technology Industry Council and the 16 Chris Cleet, QEP Consumer Technology Association 17 Timothy Reilly Clariant Corporation Panel 5 18 Rachel Weintraub Consumer Federation of America 19 Katie Huffling, RN, MS, CNM Alliance of Nurses for Family Environments 20 Kathleen A. Curtis, LPN Clean and Healthy New York Ecology Center/American Sustainable Business 21 Jeff Gearhart Council 22 Bryan McGannon American Sustainable Business Council Panel 6 23 Vytenis Babrauskas, Ph.D. Fire Science and Technology, Inc. 24 Donald Lucas, Ph.D. Lawrence Berkeley National Laboratory 25 Jennifer Sass, Ph.D.
    [Show full text]
  • Dibenzofuran-Induced Mitochondrial Dysfunction: Interaction with ANT Carrier ⇑ F.V
    Toxicology in Vitro 27 (2013) 2160–2168 Contents lists available at ScienceDirect Toxicology in Vitro journal homepage: www.elsevier.com/locate/toxinvit Dibenzofuran-induced mitochondrial dysfunction: Interaction with ANT carrier ⇑ F.V. Duarte a,b, , A.P. Gomes a,b, J.S. Teodoro a,b, A.T. Varela a,b, A.J.M. Moreno b, A.P. Rolo a,c, C.M. Palmeira a,b a CNC – Center for Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal b Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, Apartado 3046, 3001-401 Coimbra, Portugal c Department of Biology, University of Aveiro, 3810-193 Aveiro, Portugal article info abstract Article history: Exposure to environmental pollutants such as dibenzofurans and furans is linked to the pathophysiology Received 6 April 2013 of several diseases. Dibenzofuran (DBF) is listed as a pollutant of concern due to its persistence in the Accepted 26 August 2013 environment, bioaccumulation and toxicity to humans, being associated with the development of lung Available online 3 September 2013 diseases and cancers, due to its extremely toxic properties such as carcinogenic and teratogenic. Mitochondria play a key role in cellular homeostasis and keeping a proper energy supply for eukaryotic Keywords: cells is essential in the fulfillment of the tissues energy-demand. Therefore, interference with mitochon- Adenine nucleotide translocator (ANT) drial function leads to cell death and organ failure. In this work, the effects of DBF on isolated rat liver Cyclophilin D (CypD) mitochondria were analyzed. Dibenzofuran (DBF) Mitochondria DBF exposure caused a markedly increase in the lag phase that follows depolarization induced by ADP, Mitochondrial permeability transition (MPT) indicating an effect in the phosphorylative system.
    [Show full text]
  • A New Insight Into the Potential Role of Tryptophan-Derived Ahr Ligands in Skin Physiological and Pathological Processes
    International Journal of Molecular Sciences Review A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes Monika Szelest †,‡ , Katarzyna Walczak *,† and Tomasz Plech Department of Pharmacology, Medical University of Lublin, Chod´zki4a, 20-093 Lublin, Poland; [email protected] (M.S.); [email protected] (T.P.) * Correspondence: [email protected]; Tel.: +48-81-448-6774 † These authors contributed equally to this work. ‡ A Volunteer in the Department of Pharmacology, Medical University of Lublin. Abstract: The aryl hydrocarbon receptor (AhR) plays a crucial role in environmental responses and xenobiotic metabolism, as it controls the transcription profiles of several genes in a ligand- specific and cell-type-specific manner. Various barrier tissues, including skin, display the expression of AhR. Recent studies revealed multiple roles of AhR in skin physiology and disease, includ- ing melanogenesis, inflammation and cancer. Tryptophan metabolites are distinguished among the groups of natural and synthetic AhR ligands, and these include kynurenine, kynurenic acid and 6-formylindolo[3,2-b]carbazole (FICZ). Tryptophan derivatives can affect and regulate a variety of signaling pathways. Thus, the interest in how these substances influence physiological and patholog- ical processes in the skin is expanding rapidly. The widespread presence of these substances and potential continuous exposure of the skin to their biological effects indicate the important role of AhR and its ligands in the prevention, pathogenesis and progression of skin diseases. In this review, we summarize the current knowledge of AhR in skin physiology. Moreover, we discuss the role of AhR in skin pathological processes, including inflammatory skin diseases, pigmentation disorders and Citation: Szelest, M.; Walczak, K.; cancer.
    [Show full text]
  • Mechanistic Studies on the Dibenzofuran Formation from Phenanthrene, Fluorene and 9–Fluorenone
    Int. J. Mol. Sci. 2015, 16, 5271-5284; doi:10.3390/ijms16035271 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Mechanistic Studies on the Dibenzofuran Formation from Phenanthrene, Fluorene and 9–Fluorenone Shanqing Li and Qingzhu Zhang * Environment Research Institute, Shandong University, Jinan 250100, China; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +86-531-8836-4435; Fax: +86-531-8836-1990. Academic Editor: Christo Christov Received: 2 February 2015 / Accepted: 4 March 3015 / Published: 6 March 2015 Abstract: We carried out molecular orbital theory calculations for the homogeneous gas-phase formation of dibenzofuran from phenanthrene, fluorene, 9-methylfluorene and 9-fluorenone. Dibenzofuran will be formed if ·OH adds to C8a, and the order of reactivity follows as 9-fluorenone > 9-methylfluorene > fluorene > phenanthrene. The oxidations initiated by ClO· are more favorable processes, considering that the standard reaction Gibbs energies are at least 21.63 kcal/mol lower than those of the equivalent reactions initiated by ·OH. The adding of ·OH and then O2 to phenanthrene is a more favorable route than adding ·OH to C8a of phenanthrene, when considering the greater reaction extent. The reaction channel from fluorene and O2 to 9-fluorenone and H2O seems very important, not only because it contains only three elementary reactions, but because the standard reaction Gibbs energies are lower than −80.07 kcal/mol. Keywords: dibenzofuran; polycyclic aromatic hydrocarbons; formation mechanism; chlorine monoxide radical; density functional method 1. Introduction Incineration is an efficient means of waste disposal, owing to significant volume reduction and energy recovery [1].
    [Show full text]
  • Guidance for Assessing Chemical Contaminant Data for Use in Fish Advisories
    United States Office of Water EPA 823-B-00-007 Environmental Protection (4305) November 2000 Agency Guidance for Assessing Chemical Contaminant Data for Use in Fish Advisories Volume 1 Fish Sampling and Analysis Third Edition Guidance for Assessing Chemical Contaminant Data for Use in Fish Advisories Volume 1: Fish Sampling and Analysis Third Edition Office of Science and Technology Office of Water U.S. Environmental Protection Agency Washington, DC United States Environmental Protection Agency (4305) Washington, DC 20460 Official Business Penalty for Private Use $300 Guidance for Assessing Chemical Contamin Volume 1: Fish Sampling and Analysis TABLE OF CONTENTS TABLE OF CONTENTS Section Page Figures ................................................... vii Tables ................................................... ix Acknowledgments .......................................... xii Acronyms ................................................ xiii Executive Summary .......................................ES-1 1 Introduction ........................................... 1-1 1.1 Historical Perspective ............................... 1-1 1.1.1 Establishment of the Fish Contaminant Workgroup . 1-3 1.1.2 Development of a National Fish Advisory Database . 1-3 1.2 Purpose ......................................... 1-10 1.3 Objectives ....................................... 1-13 1.4 Relationship of Manual to Other Guidance Documents ..... 1-15 1.5 Contents of Volume 1 .............................. 1-15 1.6 New Information And Revisions to Volume 1 ............
    [Show full text]
  • A Gill Filament EROD Assay
    Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 920 A Gill Filament EROD Assay Development and Application in Environmental Monitoring BY MARIA JÖNSSON ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2003 !! "#!! $ % & $ $ '% %( )% * *%( + ,( !!-( . / 01 . ( . , &( . ( 2!( 3 ( ( 45 2"633 637 "68 . & $ 6 $ % % ' 3! ". 9:'".;6 % $ 6 % 901; * * 9 ; . 9 ; . % 9 ; . 9 ; % 9 ; * $$% 9! ;( * <6 % % $ 9<5= "!68 ,; % 01 % * $$%( 4 * * $ > ? @ 9 '= "!62 ,; % & 9"!67 ,; % & % % ' & % % 01 ( . :'".6 ' $ * % * & $ $% * -A6 ' (( % $ * % <5 B 9:'". % ;( )% $ ' * % 9 $ % & $ ; *% % :'". > * % $ % & $ ( A % 6 $ $ :'". $ % $ % $ '( )% % $ % % :'". > * ' 9"!6C ,; & 9"!68 ,; *% * % --D D36 % % 9"!67 ,;( . 9 ' & ; $ % ( , % * % & $ 01 B $ * 6B % % % $ &( % % && % 6B % & & $ 6 % & %$ & $ 01 % ( " # $ E > ? @ B :'". & 01 $% & & ' % &' ( ) * ( ) + ( ,-. /0!( ( )123456 ( # F , + !!- 45 ""! 6-G 45 2"633 637 "68 # ### 6-2"- 9% #HH (B(H I J # ### 6-2"-; List of Papers This thesis is based on the following papers, which are referred to in the text by their
    [Show full text]